Injectable Nanomedicines Market

1. Executive Summary

2. Introduction
     2.1. Study Objectives
     2.2. Market Definition
          2.2.1. Market Covered
          2.2.2. Geographical Coverage
          2.2.3. Study Years & Currency
     2.3. Market Stakeholders
     2.4. Key Questions this Study will Answer
     2.5. GMI Research’s Approach & Methodology

3. Global Injectable Nanomedicines Market - Overview
     3.1. Introduction
     3.2. Market Segmentation
     3.3. Drivers
     3.4. Restraints
     3.5. Trends

4. Global Injectable Nanomedicines Market Revenue Forecast till 2025

5. Global Injectable Nanomedicines Market by Product type Forecast till 2025
     5.1. Liposomes
     5.2. Micelles
     5.3. Nanocrystals
     5.4. Others

6. Global Injectable Nanomedicines Market by Indication type Revenue Forecast till 2025
     6.1. Cancers
     6.2. Central nervous system diseases
     6.3. Cardiovascular diseases
     6.4. Inflammatory diseases
     6.5. Others

7. Global Injectable Nanomedicines Market by Geography Revenue Forecast till 2025

     7.1. North America Injectable Nanomedicines Market Revenue Forecast till 2025
          7.1.1. North America Injectable Nanomedicines Market by Product type (Option 1: 25% customization)
                    7.1.1.1. Liposomes
                    7.1.1.2. Micelles
                    7.1.1.3. Nanocrystals
                    7.1.1.4. Others
          7.1.2. North America Injectable Nanomedicines Market by Indication type
                    7.1.2.1. Cancers
                    7.1.2.2. Central Nervous Systems
                    7.1.2.3. Cardiovascular Diseases
                    7.1.2.4. Inflammatory Diseases
                    7.1.2.5. Others

     7.2. Europe Injectable Nanomedicines Market Revenue Forecast till 2025

          7.2.1. Europe Injectable Nanomedicines Market by Product type (Option 2: 25% customization)
                    7.2.1.1. Liposomes
                    7.2.1.2. Micelles
                    7.2.1.3. Nanocrystals
                    7.2.1.4. Others
          7.2.2. Europe Injectable Nanomedicines Market by Indication type
                    7.2.2.1. Cancers
                    7.2.2.2. Central Nervous Systems
                    7.2.2.3. Cardiovascular Diseases
                    7.2.2.4. Inflammatory Diseases
                    7.2.2.5. Others

     7.3. Asia-Pacific Injectable Nanomedicines Market Revenue Forecast till 2025

          7.3.1. Asia-Pacific Injectable Nanomedicines Market by Product type (Option 3: 25% customization)
                    7.3.1.1. Liposomes
                    7.3.1.2. Micelles
                    7.3.1.3. Nanocrystals
                    7.3.1.4. Others
          7.3.2. Asia-Pacific Injectable Nanomedicines Market by Indication type
                    7.3.2.1. Cancers
                    7.3.2.2. Central Nervous Systems
                    7.3.2.3. Cardiovascular Diseases
                    7.3.2.4. Inflammatory Diseases
                    7.3.2.5. Others

     7.4. Rest of the World Injectable Nanomedicines Market Revenue Forecast till 2025
          7.4.1. Rest of the World Injectable Nanomedicines Market by Product type (Option 4: 25% customization)
                    7.4.1.1. Liposomes
                    7.4.1.2. Micelles
                    7.4.1.3. Nanocrystals
                    7.4.1.4. Others
          7.4.2. Rest of the World Injectable Nanomedicines Market by Indication type
                    7.4.2.1. Cancers
                    7.4.2.2. Central Nervous Systems
                    7.4.2.3. Cardiovascular Diseases
                    7.4.2.4. Inflammatory Diseases
                    7.4.2.5. Others

8. Competitive Landscape
     8.1. Porter 5 Analysis
     8.2. Major players and their key strategies

9. Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)
     9.1. Merck & Co. Inc.
          9.1.1. Company Overview
          9.1.2. Financials
          9.1.3. Recent Developments

     9.2. Lupin
          9.2.1. Company Overview
          9.2.2. Financials
          9.2.3. Recent Developments

     9.3. Pacira Pharmaceuticals Inc.
          9.3.1. Company Overview
          9.3.2. Financials
          9.3.3. Recent Developments

     9.4. Celgene Pharmaceutical Co. Ltd
          9.4.1. Company Overview
          9.4.2. Financials
          9.4.3. Recent Developments

     9.5. Amgen, Inc
          9.5.1. Company Overview
          9.5.2. Financials
          9.5.3. Recent Developments

     9.6. Janssen Biotech Inc.
          9.6.1. Company Overview
          9.6.2. Financials
          9.6.3. Recent Developments

     9.7. Pfizer Inc.
          9.7.1. Company Overview
          9.7.2. Financials
          9.7.3. Recent Developments

     9.8. Hoffmann-La Roche Ltd
          9.8.1. Company Overview
          9.8.2. Financials
          9.8.3. Recent Developments

     9.9. Teva Pharmaceutical Industries Ltd
          9.9.1. Company Overview
          9.9.2. Financials
          9.9.3. Recent Developments

     9.10. Bausch & Lomb Inc
          9.10.1. Company Overview
          9.10.2. Financials
          9.10.3. Recent Developments

10. About GMI Research